Unknown

Dataset Information

0

Improved Diabetic Wound Healing by EGF Encapsulation in Gelatin-Alginate Coacervates.


ABSTRACT: Topical imageplication of epidermal growth fctor (EGF) has been used to accelerate diabetic foot ulcers but with limited efficacy. In this study, we selected a complex coacervate (EGF-Coa) composed of the low molecular weight gelatin type A and sodium alginate as a novel delivery system for EGF, based on encapsulation efficiency and protection of EGF from protease. EGF-Coa enhanced in vitro migration of keratinocytes and accelerated wound healing in streptozotocin-induced diabetic mice with increased granulation and re-epithelialization. While diabetic wound sites without treatment showed downward growth of hyperproliferative epidermis along the wound edges with poor matrix formation, EGF-Coa treatment recovered horizontal migration of epidermis over the newly deposited dermal matrix. EGF-Coa treatment also resulted in reduced levels of proinflammatory cytokines IL-1, IL-6, and THF-?. Freeze-dried coacervates packaged in aluminum pouches were stable for up to 4 months at 4 and 25 °C in terms of appearance, purity by RP-HPLC, and in vitro release profiles. There were significant physical and chemical changes in relative humidity above 33% or at 37 °C, suggesting the requirement for moisture-proof packaging and cold chain storage for long term stability. We propose low molecular weight gelatin type A and sodium alginate (LWGA-SA) coacervates as a novel EGF delivery system with enhanced efficacy for chronic wounds.

SUBMITTER: Jeong S 

PROVIDER: S-EPMC7238057 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Improved Diabetic Wound Healing by EGF Encapsulation in Gelatin-Alginate Coacervates.

Jeong Seonghee S   Kim ByungWook B   Park Minwoo M   Ban Eunmi E   Lee Soo-Hyeon SH   Kim Aeri A  

Pharmaceutics 20200408 4


Topical imageplication of epidermal growth fctor (EGF) has been used to accelerate diabetic foot ulcers but with limited efficacy. In this study, we selected a complex coacervate (EGF-Coa) composed of the low molecular weight gelatin type A and sodium alginate as a novel delivery system for EGF, based on encapsulation efficiency and protection of EGF from protease. EGF-Coa enhanced in vitro migration of keratinocytes and accelerated wound healing in streptozotocin-induced diabetic mice with incr  ...[more]

Similar Datasets

| S-EPMC6835588 | biostudies-literature
| S-EPMC9781200 | biostudies-literature
| S-EPMC9687833 | biostudies-literature
| S-EPMC6562986 | biostudies-literature
| S-EPMC8539411 | biostudies-literature
| S-EPMC10927318 | biostudies-literature
| S-EPMC8365451 | biostudies-literature
| S-EPMC7235221 | biostudies-literature
| S-EPMC9159484 | biostudies-literature